Discover 3,075 paid clinical trials in Houston, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Houston is home to world-renowned medical centers offering a variety of trials targeting conditions such as cancer, heart disease, diabetes, and Alzheimer’s. Healthy volunteers interested in paid research opportunities, as well as individuals in need of trials for specific conditions, can participate in these studies to access cutting-edge treatments and contribute to the development of innovative therapies.
Filter
2
Filter results
Results: 3,075
Hemodynamic Management Following Acute Traumatic Spinal Cord Injury
for
Spinal Cord Injuries
Location: Houston TX
Sponsor: The University of Texas Health Science Center, Houston
Sex: All
Age: 18+
Code: NCT06451133
Recruiting
Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas
for
Ewing Sarcoma, Colorectal Adenocarcinoma
Location: Houston TX, Nashville TN, Atlanta GA, Aurora CO,
Sponsor: Inhibrx Biosciences, Inc
Sex: All
Age: 12 - 70+
Code: NCT03715933
Phase1, Recruiting
Hyperpolarized Carbon C 13 Pyruvate in Diagnosing Glioma in Patients With Brain Tumors
for
Primary Brain Neoplasm
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 19+
Code: NCT03830151
Phase1, Recruiting
GD2 Specific CAR and Interleukin-15 Expressing Autologous NKT Cells to Treat Children With Neuroblastoma
for
Neuroblastoma
Location: Houston TX
Sponsor: Baylor College of Medicine
Sex: All
Age: 1 - 21
Code: NCT03294954
Phase1, Recruiting
Surgery With or Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal Sarcoma
Location: Houston TX, Denver CO, Nashville TN, St Louis MO,
Sponsor: Nuvalent Inc.
Sex: All
Age: 18+
Code: NCT06521554
Phase1, Recruiting
Comparison of Conspicuity of Masses and Architectural Distortions Between Wide- and Narrow-angle Digital Breast Tomosynthesis Systems
for
Architectural Distortions, Breast Tomosynthesis
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: Female
Age: 0+
Code: NCT06373354
Recruiting
New Pediatric Patching Method to Improve Compliance
for
Amblyopia, Strabismus
Location: Houston TX
Sponsor: Baylor College of Medicine
Sex: All
Age: 0 - 7
Code: NCT02236351
Recruiting
PACIFIC: Primary Mediastinal Large B-cell Lymphoma Treated With Antibody Therapy, Checkpoint Inhibitor in Frontline With ImmunoChemotherapy
for
Ann Arbor Stage I Primary Mediastinal (Thymic) Large B-Cell Lymphoma,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT04745949
Phase2, Recruiting
PTM-101 in Pancreatic Ductal Adenocarcinoma (PDAC)
for
Pancreatic Ductal Adenocarcinoma,
Location: Houston TX, Dallas TX, Miami FL, Detroit MI,
Sponsor: PanTher Therapeutics
Sex: All
Age: 18+
Code: NCT06673017
Phase1, Recruiting
Real-World Evaluation Screening Study and Registry of Dyskinesia in Patients Taking Antipsychotic Agents
for
Tardive Dyskinesia
Location: Houston TX, San Antonio TX, Little Rock AR,
Sponsor: Neurocrine Biosciences
Sex: All
Age: 18+
Code: NCT03062033
Recruiting
Web-Based Program in Helping Patients With Head and Neck Cancer Adhere to Swallowing Exercises and Coping Strategies
for
Throat Carcinoma
Location: Houston TX, Fort Worth TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT04003051
Phase2, Recruiting
The Use of Cytomegalovirus Cell Mediated Immunity to Optimize the Duration of Letermovir Prophylaxis in Hematopoietic Cell Transplant Recipients
for
Cytomegalovirus Cell Mediated Immunity,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT06639854
Recruiting
Evaluation of a New Strategy for Protocolized Antibiotic Care for Severe Open Fractures: SEXTANT 2
for
Post Operative Surgical Site Infection
Location: Houston TX, New Orleans LA, Jackson MS,
Sponsor: Major Extremity Trauma Research Consortium
Sex: All
Age: 18 - 64
Code: NCT04678154
Phase3, Recruiting
Open-label Phase 1b Study of Ulixertinib and Cetuximab or Ulixertinib in Combination With Cetuximab and Encorafenib in Patients With Unresectable or Metastatic Colorectal Cancer Who Have Previously Received EGFR or BRAF-directed Therapy
for
Metastatic Colorectal Cancer
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT05985954
Phase1, Recruiting
Clinical Study of Anti-FLT3 CAR-T Cells for the Treatment of Relapsed/Refractory AML